IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance
IM Cannabis Corp. (IMCC) plans a 30:1 share consolidation by September 15, 2026, to meet Nasdaq's $1.00 minimum bid price requirement. The company expects 603,922 shares post-consolidation, with trading to resume on August 27, 2026. The move aims to regain compliance with Nasdaq's listing rules.
How this was made
The 30-second read
Why it matters
The consolidation reduces share count from 18.12M to about 0.60M and is expected to restart trading on a post-consolidation basis at the Aug. 27, 2026 open, subject to Nasdaq confirmation. The company has until Oct. 6, 2026 to regain compliance by closing at least $1.00 for 10 consecutive business days.
Market read
This is a concrete corporate action with a defined ratio and expected trading date, directly tied to Nasdaq listing compliance timing.
What to watch
Traders should focus on post-split liquidity and the adjusted conversion/exercise terms for outstanding convertibles, which can affect hedging and supply/demand dynamics.
Background
IM Cannabis (Nasdaq: IMCC) is executing a 30:1 share consolidation to address Nasdaq’s $1.00 minimum bid price requirement for continued listing.
Ticker impact
IM Cannabis approved a 30:1 share consolidation to raise its Nasdaq bid price and regain compliance with the $1.00 minimum.
Near-term volatility is likely around the Aug. 27 effective trading date, but direction depends on whether the market views the compliance plan as credible versus dilution/liquidity risk.
The article discloses the exact consolidation ratio, expected effective date, and the Nasdaq compliance deadline (Oct. 6, 2026), which are actionable for timing and risk management. It does not provide new fundamentals beyond the compliance mechanism.
Market effects
Microcap cannabis issuers may face similar Nasdaq bid-price pressure, making reverse-split risk a recurring theme for the group.
Limited broader regional impact; primarily affects the company’s US-listed trading and liquidity profile.
Low global relevance; this is a Nasdaq listing compliance action rather than a cross-border operating change.
Counterpoint
A reverse split can fail to restore compliance if investor demand remains weak, so the action may not prevent further listing risk.
Key entities
- public_companyIM Cannabis Corp.
Nasdaq-listed medical cannabis company announcing a 30:1 share consolidation to regain Nasdaq minimum bid compliance.
- venueNasdaq Capital Market
Exchange setting the $1.00 minimum bid price requirement and compliance process referenced in the release.
- service_providerComputershare Investor Services Inc.
Registrar and transfer agent that will send exchange instructions to registered shareholders.
